|
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial |
|
|
|
Titel: |
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial |
Auteur: |
Hida, Toyoaki Nokihara, Hiroshi Kondo, Masashi Kim, Young Hak Azuma, Koichi Seto, Takashi Takiguchi, Yuichi Nishio, Makoto Yoshioka, Hiroshige Imamura, Fumio Hotta, Katsuyuki Watanabe, Satoshi Goto, Koichi Satouchi, Miyako Kozuki, Toshiyuki Shukuya, Takehito Nakagawa, Kazuhiko Mitsudomi, Tetsuya Yamamoto, Nobuyuki Asakawa, Takashi Asabe, Ryoichi Tanaka, Tomohiro Tamura, Tomohide |
Verschenen in: |
Lancet |
Paginering: |
Jaargang 390 (2017) nr. 10089 pagina's 11 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|